Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gomez–Almaguer D et al. – Median complete blood count values on alemtuzumab responders were Hb 13.1 mg/dL, absolute neutrophil count 2.4 × 109/L, and platelets 97.5 × 109/L. A good response was produced in 57% of AA patients with the administration of alemtuzumab, who lacked a stem cell donor.

Related Articles

Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia
International Journal of Hematology, 10/23/09    Relevance Score: 69%

Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT
Bone Marrow Transplantation, 11/19/09    Relevance Score: 67%

Aplastic anemia in the orient
International Journal of Hematology, 10/07/09    Relevance Score: 67%

New advances in the treatment of acquired severe aplastic anaemia
International Journal of Hematology, 10/07/09    Relevance Score: 67%

The relationship of aplastic anemia and PNH
International Journal of Hematology, 10/07/09    Relevance Score: 67%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address